NOVAVAX INC — Director's Dealing 2014

Aug 4, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2014-07-31

Reporting Person: Glenn Gregory M (SVP, Research and Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-31	Common Stock	P	12707	$2.28	Acquired	16809	Direct

Footnotes

F1: Includes 12,707 shares acquired under the Issuer's 2013 Employee Stock Purchase Plan on July 31, 2014.